Many eye conditions can be easily treated if those at risk undergo regular eye examinations, and are informed about good ...

Bausch + Lomb announced today that an affiliate acquired Elios Vision, developer of a minimally invasive glaucoma surgery ...

According to the partners, glaucoma research to be led by internationally renowned glaucoma surgeon Ike Ahmed, MD, FRCSC, ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that an affiliate has acquired Elios Vision, Inc.

ViaLase, Inc., a clinical-stage medical technology company focused on addressing unmet needs in the conventional glaucoma treatment paradigm, today announced a research partnership with the John A.

Zhaoke Ophthalmology Ltd. (HK:6622) has released an update. Zhaoke Ophthalmology Ltd. has secured marketing authorizations ...

Glaukos (GKOS) has received a new Buy rating, initiated by UBS analyst, Danielle Antalffy.Don't Miss our Black Friday Offers:Unlock your ...

A generic latanaprost solution from Gland Pharma has received FDA approval for the treatment of open angle glaucoma and ocular hypertension.

Glaucoma is a leading cause of global blindness. Intraocular pressure (IOP) remains the only clinically-validated and ...

Glaucoma is a sneaky eye condition that often goes unnoticed until significant damage has been done. It affects the optic ...

Nocturnal intraocular pressure (IOP) profiling has shown that the peak IOP usually occurs at night, particularly in patients with glaucoma. Multiple studies have demonstrated that these ...

According to IQVIA, the product had US sales of approximately USD 111.6 million for the twelve months ending 2023.